Literature DB >> 444589

Regulation of cytosol and nuclear progesterone receptors in rabbit uterus by estrogen, antiestrogen and progesterone administration.

V Isomaa, H Isotalo, M Orava, O Jänne.   

Abstract

A synthetic progestin, 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione (ORG 2058), was utilized to measure progesterone receptors from the rabbit uterus. This steroid has a high affinity for both cytosol and nuclear receptors, with KD values of 1.2 nM (at 0--4 degrees C) and 2.3 nM (at 15 degrees C), respectively. Administration of estradiol-17 beta or a non-steroidal antiestrogen, tamoxifen, for 5 days to estrous rabbits led to a progressive rise in the cytosol receptor levels: from 34,000 to 120,000 (estradiol-17 beta) and 80,000 (tamoxifen) receptors/cell, without any major influence on the nuclear receptor content. A single intravenous injection of progesterone (5 mg/kg) elicited a 3-fold increase in the mean nuclear receptor content at 30 min after injection (from 18,000 to 48,000 receptors/nucleus). Nuclear receptor accumulation was short-lived and returned to control levels within 4 h after treatment. A second dose of progesterone given 24 h later doubled the nuclear receptor level (from 18,000 to 35,000 receptors/nucleus). The concomitant decline in the cytosol receptor content was twice that accounted for by the nuclear receptor accumulation (70,000 vs. 30,000, and 40,000 vs. 17,000 receptors/cell, after the first and second progesterone injection, respectively). Following progesterone administration, the cytosol receptor level reached a nadir by 30 min, exhibited minimal replenishment within the ensuing 24 h, and remained at approx. 50% of the pretreatment values. After a single dose or two consecutive doses of progesterone, total uterine progesterone receptor content declined to about 60% of the level prior to each dose, a nadir being reached at 2 h after treatment.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 444589     DOI: 10.1016/0304-4165(79)90321-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Immunohistochemical localization of oestrogen receptors and progesterone receptors in the human ovary throughout the menstrual cycle.

Authors:  T Iwai; Y Nanbu; M Iwai; S Taii; S Fujii; T Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 2.  Mechanisms and significance of nuclear receptor auto- and cross-regulation.

Authors:  Pia Bagamasbad; Robert J Denver
Journal:  Gen Comp Endocrinol       Date:  2010-03-23       Impact factor: 2.822

3.  A short luteal phase in cycles stimulated with clomiphene and human menopausal gonadotropin for in vitro fertilization.

Authors:  T Laatikainen; H Kurunmäki; A Koskimies
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-02

4.  A comparison of the relationships between progestin receptors and oestrogen receptors in neural and non-neural target tissues of the rat during the oestrous cycle.

Authors:  S Thrower; L Lim
Journal:  Biochem J       Date:  1980-09-15       Impact factor: 3.857

5.  Bovine uterine, cervical and ovarian androgen receptor concentrations. Correlation with estrogen and progesterone receptor concentrations.

Authors:  M Vesanen; V Isomaa; M Alanko; R Vihko
Journal:  Acta Vet Scand       Date:  1992       Impact factor: 1.695

6.  Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene.

Authors:  J F Savouret; A Bailly; M Misrahi; C Rauch; G Redeuilh; A Chauchereau; E Milgrom
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

7.  Ultrastructural localization of the progesterone receptor by an immunogold method: effect of hormone administration.

Authors:  M Perrot-Applanat; M T Groyer-Picard; F Logeat; E Milgrom
Journal:  J Cell Biol       Date:  1986-04       Impact factor: 10.539

8.  Oestrogen receptor isoforms, their distribution and relation to progesterone receptor levels in breast cancer samples.

Authors:  V A Baker; J R Puddefoot; S Marsigliante; S Barker; A W Goode; G P Vinson
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.